Susceptibility of bovine to SARS-CoV-2 variants of concern: insights from ACE2, AXL, and NRP1 receptors

被引:0
|
作者
Ma, Ying [1 ]
Lei, Mengyue [1 ]
Chen, Hongli [1 ,3 ]
Huang, Pu [1 ]
Sun, Jing [1 ]
Sun, Qiangming [2 ]
Hu, Yunzhang [1 ]
Shi, Jiandong [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Yunnan Prov Key Lab Vector Borne Dis Control & Res, 935 Jiaoling Rd, Kunming, Yunnan 650118, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Natl Kunming High Level Biosafety Primate Res Ctr, 935 Jiaoling Rd, Kunming 650118, Yunnan, Peoples R China
[3] Kunming Med Univ, Kunming, Yunnan, Peoples R China
关键词
ACE2; AXL; NRP1; Cross-species transmission; Receptor; SARS-CoV-2; variants; IMPACT;
D O I
10.1186/s12985-023-02222-9
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The possibilities of cross-species transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) between humans and important livestock species are not yet known. Herein, we used the structural and genetic alignment and surface potential analysis of the amino acid (aa) in angiotensin-converting enzyme 2 (ACE2), tyrosine kinase receptor UFO (AXL), and neuropilin 1 (NRP1) in different species with substantial public health importance. The residues interfacing with the N-terminal domain (NTD) or receptor-binding domain (RBD) of S were aligned to screen the critical aa sites that determined the susceptibility of the SARS-CoV-2 to the host. We found that AXL and NRP1 proteins might be used as the receptors of SARS-CoV-2 in bovines. However, ACE2 protein may not be considered to be involved in the cross-species transmission of SARS-CoV-2 VOCs in cattle because the key residues of the ACE2-S-binding interface were different from those in known susceptible species. This study indicated that emerging SARS-CoV-2 variants potentially expand species tropism to bovines through AXL and NRP1 proteins.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Differential Ability of Spike Protein of SARS-CoV-2 Variants to Downregulate ACE2
    Maeda, Yosuke
    Toyoda, Mako
    Kuwata, Takeo
    Terasawa, Hiromi
    Tokugawa, Umiru
    Monde, Kazuaki
    Sawa, Tomohiro
    Ueno, Takamasa
    Matsushita, Shuzo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [22] Research progress of biosensors for detection of SARS-CoV-2 variants based on ACE2
    Wei, Hongshuai
    Zhang, Congcong
    Du, Xin
    Zhang, Zhenguo
    TALANTA, 2023, 251
  • [23] Can ACE2 Receptor Polymorphism Predict Species Susceptibility to SARS-CoV-2?
    Devaux, Christian A.
    Pinault, Lucile
    Osman, Ikram Omar
    Raoult, Didier
    FRONTIERS IN PUBLIC HEALTH, 2021, 8
  • [24] In silico investigations of heparin binding to SARS-CoV-2 variants with a focus at the RBD/ACE2 interface
    Ali, Nemat
    Khan, Rehan
    AlAsmari, Abdullah F.
    Kumar, Vijay
    PROCESS BIOCHEMISTRY, 2022, 115 : 70 - 79
  • [25] ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
    Saponaro, Federica
    Rutigliano, Grazia
    Sestito, Simona
    Bandini, Lavinia
    Storti, Barbara
    Bizzarri, Ranieri
    Zucchi, Riccardo
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
  • [26] ACE2 coding variants in different populations and their potential impact on SARS-CoV-2 binding affinity
    Ali, Fedaa
    Elserafy, Menattallah
    Alkordi, Mohamed H.
    Amin, Muhamed
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2020, 24
  • [27] SARS-CoV-2, ACE2 expression, and systemic organ invasion
    Ashraf, Usman M.
    Abokor, Ahmed A.
    Edwards, Jonnelle M.
    Waigi, Emily W.
    Royfman, Rachel S.
    Hasan, Syed Abdul-Moiz
    Smedlund, Kathryn B.
    Hardy, Ana Maria Gregio
    Chakravarti, Ritu
    Koch, Lauren Gerard
    PHYSIOLOGICAL GENOMICS, 2021, 53 (02) : 51 - 60
  • [28] Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants
    Ebene R. Haycroft
    Samantha K. Davis
    Pradhipa Ramanathan
    Ester Lopez
    Ruth A. Purcell
    Li Lynn Tan
    Phillip Pymm
    Bruce D. Wines
    P. Mark Hogarth
    Adam K. Wheatley
    Jennifer A. Juno
    Samuel J. Redmond
    Nicholas A. Gherardin
    Dale I. Godfrey
    Wai-Hong Tham
    Kevin John Selva
    Stephen J. Kent
    Amy W. Chung
    Medical Microbiology and Immunology, 2023, 212 : 291 - 305
  • [29] ACE2: The Major Cell Entry Receptor for SARS-CoV-2
    Scialo, Filippo
    Daniele, Aurora
    Amato, Felice
    Pastore, Lucio
    Matera, Maria Gabriella
    Cazzola, Mario
    Castaldo, Giuseppe
    Bianco, Andrea
    LUNG, 2020, 198 (06) : 867 - 877
  • [30] Structural insights into ACE2 interactions and immune activation of SARS-CoV-2 and its variants: an in-silico study
    Yousefbeigi, Sarina
    Marsusi, Farah
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2025, 43 (02) : 665 - 678